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Abstract 
Baculovirus-insect cell expression system has become one of the most widely used eukaryotic 
expression systems for heterologous protein production in many laboratories. The availability of 
robust insect cell lines, serum-free media, a range of vectors and commercially-packaged kits have 
supported the demand for maximizing the exploitation of the baculovirus-insect cell expression 
system. Naturally, this resulted in varied strategies adopted by different laboratories to optimize 
protein production. Most laboratories have preference in using either the E. coli transposition-based 
recombination bacmid technology (e.g. Bac-to-Bac®) or homologous recombination transfection 
within insect cells (e.g. flashBAC™). Limited data is presented in the literature to benchmark the 
protocols used for these baculovirus vectors to facilitate the selection of a system for optimal 
production of target proteins. Taking advantage of the Protein Production and Purification 
Partnership in Europe (P4EU) scientific network, a benchmarking initiative was designed to 
compare the diverse protocols established in thirteen individual laboratories. This benchmarking 
initiative compared the expression of four selected intracellular proteins (mouse Dicer-2, 204 kDa; 
human ABL1 wildtype, 126 kDa; human FMRP, 68 kDa; viral vNS1-H1, 76 kDa). Here, we present 
the expression and purification results on these proteins and highlight the significant differences in 
expression yields obtained using different commercially-packaged baculovirus vectors. The highest 
expression level for difficult-to-express intracellular protein candidates were observed with the 
EmBacY baculovirus vector system. 
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1. Introduction 
Baculovirus-insect cell expression system is a workhorse in many research laboratories for 
recombinant protein production. Its superiority for the expression of complex proteins to prokaryotic 
Escherichia coli expression host is well-demonstrated by the use of the technology for routine 
production of glycoproteins, G-protein-coupled receptors (GPCRs), virus-like particles (VLPs) and 
‘difficult-to-express’ mammalian proteins. Further validation of the baculovirus expression technology 
is demonstrated by the commercial manufacture of human and veterinary vaccines using this 
expression system, including GSK’s human papillomavirus VLP vaccine (Deschuyteneer et al., 2010), 
Protein Sciences’ influenza hemagglutinin (HA) vaccine (Cox and Hollister, 2009) and porcine 
circovirus ORF2 vaccine (Fan et al., 2007). A steady increase in both published scientific papers and 
patents citing the use of baculovirus-insect cell expression system is observed over the last 30 years 
(van Oers et al., 2015). 
Although baculovirus-insect cell expression system is a ready-to-use system, largely due to the 
availability of commercial baculovirus expression kits complete with vector, cell line, medium and 
detailed protocols, there are multiple factors to consider and optimize for the production of proteins. 
Developments in engineering baculovirus Autographa californica multicapsid nucleopolyhedrovirus 
(AcMNPV) for improved recombination efficiency (bacmid technology or homologous 
recombination), ease of production for multisubunit protein complexes (single baculovirus vector) and 
improved glycoprotein expression (gene deletion or inclusion) further broaden the variety of 
baculovirus expression systems. The two most commonly used commercial baculovirus systems are 
Bac-to-Bac
®
 (transposition-based bacmid technology) and flashBAC
TM
 (homologous recombination). 
In general, a research laboratory chooses one system over another depending on the cost and 
availability, whereas little attention is given to the protein quality and quantity of the same protein 
construct across different baculovirus expression systems. Similarly, there is limited literature to guide 
the selection of the optimal insect cell line or the inherent cell culture medium. Clonal isolates of 
Spodoptera frugiperda and Trichoplusia ni are the most commonly used cell lines for protein 
production.  
  
 
The network of P4EU (Protein Production and Purification Partnership in Europe) has international 
protein production facilities spread across > 40 countries. These facilities’ core service is to accelerate 
research through the provision of high quality proteins to researchers working in diverse disciplines. 
As an effort to enhance shared knowledge and learnings in the field of recombinant protein 
production, a benchmarking was conducted to compare the efficiency and productivity of baculovirus-
insect cell expression methods adopted in the individual laboratories. This initiative examined and 
compared the performance of each participating laboratory on the production of four selected 
intracellular protein candidates using its existing materials and processes. This benchmarking 
highlights the range of variables between laboratories. Here, we present the results obtained by 
thirteen laboratories on the four intracellular protein candidates, narrowing down the single most 
impactful factor on protein yield when using the baculovirus-insect cell expression system. 
 
2. Materials and methods 
2.1. Selected target genes 
Four genes were selected for benchmarking (Table 1): mouse Dicer-2 (Dcr-2), MW 204 kDa; 
human ABL1 wildtype, MW 126 kDa; human FMRP, MW 68 kDa; viral vNS1-H1, MW 76 
kDa.  All proteins localized intracellularly and were N-terminally fused to 6xHis to enable a 
uniform sample analysis and protein purification procedure. The selection of these candidates 
was to challenge the participating laboratories with difficult-to-express proteins. Expression 
of these proteins in E.coli had previously failed. When previously expressed in insect cells 
using BEVs, low yields (< 1 mg/L) and poor protein stability or solubility were obtained. 
Drosophila melanogaster Dicer-2 is a member of the ribonuclease III family and is essential 
in the host defense against RNA viruses mediated by the RNA induced silencing complex 
(RISC). The role of Dicer-2 is to trim double-stranded RNAs into small-interfering RNAs 
(siRNAs), which play an essential role in RNA interference (Lee et al., 2004). ABL1 is a non-
receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth 
  
 
and survival such as cytoskeleton remodelling in response to extracellular stimuli, cell 
motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis 
(Colicelli, 2010). ABL1 and Dicer-2 protein samples purified from insect cells using BEVs 
were heavily degraded. Loss of Fragile X mental retardation protein (FMRP) causes Fragile X 
syndrome which is the most common genetically inherited form of cognitive impairment 
(Till, 2010). The isoform 2 of FMRP used in this study was expressed at 1.5 mg/L but was 
only partly soluble. NS1-H1 is a major viral nonstructural protein [H-1 parvovirus] of 
unknown function. 
2.2. Design of the study  
The selected target genes listed in Table 1, originally provided in pFastBac backbones were 
re-cloned into pBac1 for users of flashBAC™ and similar baculovirus variants. The design of 
the benchmarking study is shown in Fig. 1. The pFastBac and pBac1 plasmids were 
distributed to the respective BEVS users, among them seven laboratories using Bac-to-Bac
®
, 
MultiBac® or EMBacY and seven laboratories using flashBAC™ and similar baculovirus 
variants. Participating laboratories were asked to proceed with their routine procedures for 
virus generation and small-scale optimization; to produce each construct at 500 mL scale; to 
sample triplicates of 500 µL cell pellets for total lysate analysis and duplicates of 10 mL cell 
pellets for protein purification. Cell pellets were washed twice in PBS before freezing in 
liquid nitrogen. Non-infected control cells were included for each cell type used, cell counts 
and viability recorded and provided together with protocols (Table 2 and Supplementary S1). 
The 500 µL cell pellets were shipped on dry ice to two different sites (VBCF Vienna and 
MPIB Martinsried) for central sample analysis by two different and independent methods to 
exclude any method bias. 10 mL frozen cell pellets that were prepared for protein purification 
and quality assessment were also centralized at one site (MPIB Martinsried) to exclude 
impact of protein purification on the benchmark results.  
  
 
2.3. Participating Protein Production Facilities 
This benchmark study was initiated by members of the Protein Production and Purification 
network P4EU (https://p4eu.org) who provide central scientific services for recombinant 
protein production and purification, mainly in E. coli, mammalian and insect cells. Although 
originally founded as a European network, members also include laboratories from outside 
the Eurozone. All participants as displayed in the authors list provide services for scientific 
groups and are typically financially supported by their respective institutions. In order not to 
compromise participants for potential low performance, especially with respect to the 
challenging target genes selected for this study, participating labs were anonymized by letters.  
2.4. General protein expression procedures 
The most relevant parameters for baculovirus-driven protein expression in insect cells 
adopted by the participating labs are listed in Table 2 (full details described in Supplementary 
S1). The two different strategies for target gene integration into the baculovirus genome are 
each represented by seven participating laboratories. Lab E, F, I, H, L, M, and X belong to the 
group which uses Tn7 transposition-based integration of the target gene from the pFastBac 
transfer plasmids into the baculovirus genome within E.coli cells. Bacmids belonging to this 
group used in the present study are Bac-to-Bac
®
 (Invitrogen), MultiBac® (Berger et al., 2013) 
and EMBacY (Bieniossek et al., 2008). With the second strategy, herein called 
recombination-based transfection, recombinant baculovirus is generated directly in insect 
cells by cotransfecting the pBac1 transfer plasmids with bacmid DNA. Non-recombinant viral 
DNA is replication-incompetent, allowing propagation of recombinant virus only. 
Baculovirus variants used in this study based on this principle are flashBAC™ and 
flashBACULTRA™ (Oxford Expression Technologies OET). ProGreenTM (AB Vector) and 
an in-house chiA and v-cath deleted bacmid variant “DefBac” (manuscript in preparation by 
lab U). ProGreen
TM
 and DefBac are recombination-based methods that are adapted from the 
  
 
flashBAC procedure. Lab C, D, F, K, R, U and V belong to the users of recombinant-based 
transfection. Lab F contributed expression samples for both systems, except NS1-H1 in Bac-
to-Bac® and ABL1 in flashBACULTRA™. Insect cell lines that have been used by the 
laboratories are Spodoptera frugiperda (Sf21 and Sf9) and / or Trichoplusia ni (Hi5). All 
groups cultivated cells in suspension in different commercial media (except one proprietary 
recipe) as listed: ESF 921™ or III serum free medium (SFM) (Invitrogen), ESF 921™ 
(Expression Systems), Insect-XPRESS™ (BioWhittaker), EX-CELL® 405 for Hi5 cells and 
EX-CELL® 420 for Sf21/Sf9 cells (Sigma), and SFX-Insect (GE Healthcare). The amount of 
baculovirus used for infecting expression cultures, cell density at infection, expression time 
and expression temperature was either constant or have been adjusted individually for each of 
the four constructs (indicated by ranges e.g. virus dilution 1:100 – 1:35). 
2.5. Analysis and quantification of protein expression levels 
Quantitative comparison of expression levels in total lysates was performed on Amersham 
Easy SDS-PAGE (MPIB Martinsried) and Simple Western (VBCF Vienna) to cover sample 
analysis with methods that are complementary in sensitivity, specificity and dynamic range 
and use different electrophoretic separation principles. Easy SDS-PAGE (Amersham WB 
system, GE Healthcare) uses conventional acrylamide electrophoresis combined with 
labelling of lysine residues with sulfonated Cy5 at low dye to protein ratios (Bjerneld et al., 
2015). Gels are automatically scanned post-run and quantitative data displayed as peak lists. 
Sensitivity and dynamic area are high, ranging from 1 ng/µL up to 20 µg/µL. Cell pellets 
were thawed on ice and resuspended to a concentration of 1 x 10
6
 cells/mL in 20 mM Tris pH 
8.0 + 0.25% SDS according to the viable cell count, boiled for 5 min and spun down. Gel 
samples were prepared by mixing 2 µL cell suspension with 17 µL labelling buffer and 1 µL 
Cy5, incubated 30 min at room temperature, mixed with 20 µL loading buffer, boiled for 3 
min and loaded on 13.5% Easy SDS-gels. Data were displayed as % of total peak intensity at 
  
 
the respective size compared to non-infected control cells, circumventing the need for any 
normalization. Although being very sensitive, the lack of specificity allows detection of 
significant overexpression in total lysates versus control cells with a threshold of at least 2.5 
% of total. Simple Western (Peggy
TM
, Protein Simple) is a capillary-based immunoassay 
platform that performs automated protein separation, detection and quantification. The 
Peggy
TM
 instrument has similar sensitivity and somewhat improved dynamic range as 
compared with traditional Western blotting with chemiluminescence, with additional 
advantages of improved reproducibility due to automation of many manual steps, enabling 
quantitative comparison of protein amounts across samples (Rustandi et al., 2012). In some 
cases, proteins may show an aberrant migration behaviour in capillary protein separation. Cell 
pellets were thawed on ice and resuspended to a concentration of 1 x 10
6
 cells / mL in PBS + 
0.1% SDS according to the viable cell count. This stock was diluted 4-fold with PBS + 0.1% 
SDS, and total protein content was measured with the OPA assay (ThermoFisher Scientific) 
and compared to a standard curve using known concentrations of BSA. If necessary, lysates 
were further diluted to a concentration below 1 mg/mL to be within the linear range of the 
OPA assay. The 4-fold diluted total lysate sample was mixed with Simple Western loading 
buffer (7.5 µL sample and 2.5 µL 4X loading buffer), boiled for 5 min, spun down and 5 µL 
were loaded into a 384-well Simple Western plate for analysis. For immunodetection, primary 
anti-penta-His antibody (Qiagen) at a dilution of 1:20 and secondary HRP-labeled anti-mouse 
antibody (Protein Simple) were used. Peak areas were calculated for each sample using the 
Compass software (Protein Simple) and normalized using the total protein concentration 
determined by the OPA assay. Samples outside the linear range of detection (as determined 
by either no signal or detection of signal saturation, i.e. “burn-out”, using the Compass 
software) were re-measured using higher or lower dilutions. For conventional SDS-PAGE 
analysis (Fig. 6), protein samples were analyzed on a 4-12% Bis-Tris SDS-polyacrylamide gel 
under reduced and denatured conditions. Equal volumes of cell pellets were loaded and 
  
 
stained with SimplyBlue
TM
 SafeStain (Thermo Fisher Scientific). Target protein expression 
level as a % of total cellular protein was quantified using Chemi-Doc
TM
 XRS+ imaging 
system (Bio-Rad Laboratories, CA, USA).   
2.6. Protein purification and quality assessment 
Prior to processing all benchmark samples, purification of the four 6xHis-fusion proteins by 
immobilized metal affinity chromatography (IMAC) was optimized with regard to detergents 
to increase solubility especially of FMRP and with regard to the type of Ni
2+
-beads optimal 
for binding large proteins as Dicer-2 and cABL1. Based on these test purifications, different 
procedures were used for isolation of the four proteins. Buffers contained 50 mM Tris pH 8.0, 
500 mM NaCl, 2 mM MgCl2, 10% glycerol, 1 mM TCEP plus imidazole at 10 mM (lysis), 20 
mM (wash) and 250 mM (elution) final concentration. Protease inhibitors (final 
concentration: AEBSF-HCl 1 mM, Aprotinin 2 µg/mL, Leupeptin 1 µg/mL, Pepstatin 1 
µg/mL) and 750 U Benzonase (Novagen, Cat No 70664-3) were added to all lysis buffers. For 
purification of FMRP, Chaps was added to all buffers at 0.5%. Purification of Dicer-2 and 
ABL1 was automated on a Tecan Freedom Evo 150. Cell pellets from 10 mL cultures were 
resuspended in 2 mL lysis buffer and lysed by sonication on a Vibra Cell VC750 (Sonics and 
Materials, Inc, Newton) equipped with a 24 tip horn (Qsonica, LLC, Newton). Lysates were 
centrifuged for 30 min at 13,200 rpm at 4 °C.  1.3 mL of lysate supernatants were loaded on 
MediaScout RoboColumns columns (Atoll, Germany) filled with 50 µL Chelating Sepharose 
FF (GE Healthcare), washed 9x with 800 µL lysis buffer and eluted 3x in 60 µL elution 
buffer. Cell pellets of FMRP and vNS1-H1 were resuspended in 1.4 mL lysis buffer, lysed in 
a Dounce homogenizer and centrifuged for 30 min at 20,000 rpm at 4 °C. Lysate supernatants 
were loaded on 50 µL MagneHis particles (Promega), rotated for 60 min at 4 °C, washed 3x 
in 200 µL wash buffer and eluted 3x in 60 µL elution buffer. Protein quantitation was 
performed by Bradford staining (Pierce, Thermo Scientific) and protein containing fractions 
  
 
were pooled. Sample analysis by Easy SDS-PAGE was performed immediately after elution. 
For electrophoresis, 2 µL imidazole eluate was mixed with 17 µL labelling buffer and 1 µL 
Cy5, incubated 30 min at room temperature, mixed with 20 µL loading buffer, boiled for 3 
min and loaded on 13.5% Easy SDS-gels. For dynamic light scattering (DLS), 120 µL 
samples from both purification procedures were transferred  into a flat-bottom polystyrene 96 
well plate (Greiner, Germany) and analyzed on the Wyatt DynaPro Plate Reader. DLS data 
were recorded using a small number of short acquisitions (10 acquisitions for 5 sec each) in 
two consecutive runs. Further replicates were not recorded for reasons of limited protein 
stability. 
 
3. Results and Discussion 
3.1. Output of different facilities: protein expression levels 
In a first series of experiments, overexpression levels of all four constructs were analysed by 
Easy SDS-PAGE and Simple Western. Total lysates were produced on site for the two 
different measurements (see Materials and Methods) from 500 µL cell pellet aliquots derived 
from 500 mL-scale productions, that had been performed using the individual routine 
protocols of the different laboratories (Table 2 and Supplementary S1). Datasets from Easy 
SDS-PAGE and Simple Western are available for all four constructs and all participants. 
Representative images for results from Labs L, M and R analysed by Easy SDS-PAGE and 
Simple Western are shown in Fig. 2A and B. Intensity quantification of Cy5-labelled 
overexpressed proteins in Easy SDS-PAGE allows for display of expression levels directly as 
[%] of total peak intensity. Accordingly, Dicer-2 is expressed at levels ranging from 13% - 
23%; ABL1 from undetectable to 23%; FMRP from undetectable to 27% and NS1-H1 from 
undetectable to 16% in Lab M, L and R. It is important to note that for determining 
expression levels, only proteins of the expected size (‘intact proteins’) were included in 
  
 
positive results. Fig. 2A illustrates such an example: Dicer-2 is well expressed in lab L, but 
migrates at 117 kDa according to sizing based on internal molecular weight marker 
calibration by the Amersham WB software (red arrowhead in Fig. 2A). Such results were 
considered as 0 % expression level. This degradation product was also detected in the 
respective Simple Western analysis (Fig. 2B, red arrowhead). The quantitative comparison of 
expression levels between the 13 different laboratories for all four constructs and the two 
measurement series are shown in Fig. 3A-D. In order to compare the different datasets side-
by-side, the highest value within each dataset was set to 100% performance and all values 
within the respective dataset normalized in relation to the highest value (original data listed in 
Supplementary S2). Datasets produced with either Easy SDS-PAGE or Simple Western are in 
reasonable agreement with one major exception: expression of full-length Dicer-2 by Lab I 
could not be detected in Simple Western but in Easy SDS-PAGE. As discussed in Materials 
and Methods, discrepancies may arise from the need to normalize the data to account for 
differences in total protein levels in the Simple Western analysis and the difference between 
the detection methods used. Dicer-2 and ABL1 expression by Lab X was not monitored by 
Simple Western analysis, see * in bar graph (Fig. 3). Most important, all datasets support the 
following key observations. First, differences in performance between the 13 laboratories are 
enormous, showing the following range based on Cy5-labelling derived expression levels 
underlying Fig. 3 A-D : Dicer-2 expression levels range from undetectable (lab C, D, V) to 23 
% of total cellular protein (lab M, Figs. 2A and 3A); ABL1 expression levels range from 
undetectable (lab F, I, L, K, C, D, V) to 23% of total cellular protein (Lab M (Figs 2A and 
3B); FMRP is expressed at considerable levels in most labs, with up to 43% of total cellular 
protein in lab X (Fig. 3C and S2) and NS1-H1 expression levels range from undetectable (lab 
L, V) to 16% of total cellular protein (lab R, Figs. 2A and 3D). Second, differences in 
performance are most pronounced for expression of Dicer-2 and ABL1 (Fig. 3AB). 6 out of 
13 labs failed to express Dicer-2 at detectable or significant levels and 7 out of 14 labs 
  
 
expressed ABL1 at levels not detectable by Simple Western analysis. As mentioned in 
Materials and Methods and also supported by our data, these two proteins have been included 
in this study to challenge the performance of the individual procedures because they are 
known to be difficult-to-express and prone to degradation. With regard to these two target 
proteins, the excellent performance of the procedures used in Lab M, H, X and R are 
particularly noticeable.  
3.2. Output of different facilities: protein yields  
Although the analysis of expression levels in total lysates was very informative with regard to 
differences in performances of the diverse procedures, it does not address their impact on 
protein solubility and stability. To address these questions, all four proteins were purified as 
described in Materials and Methods from cell pellets of 10 mL from the previously described 
500 mL productions used for analysis of total lysates. Representative Easy SDS-PAGE results 
for IMAC purifications from Lab M, R and U are shown in Fig. 4A. Intensity quantification 
of Cy5-labelled purified proteins allows for the display of purity directly as [%] of total peak 
intensity. As expected, eluates of Dicer-2 and ABL1, both degradation-prone proteins, 
showed poor purity, less than 10% and 25% respectively. On the other hand, FMRP and NS1-
H1 were eluted with purities of up to 66% (lab M) and 96% (lab U) respectively from this 
single IMAC step. In order to compare performance of all participating labs taking into 
account the different degrees of purity, the amount of protein eluted from IMAC was 
corrected by its purity determined by Easy SDS-PAGE (original data listed in Supplementary 
S3). Again, highest purity-corrected protein yield was set to 100% and all other data related to 
it (Fig. 4AB). Absolute values for the highest purity-corrected yields obtained were: Dicer-2: 
3 mg/L; ABL1: 4 mg/L, FMRP: 25 mg/L; NS1-H1: 18 mg/L. Differences in performance 
derived from protein yields are in good agreement with results from the analysis of expression 
levels in total lysates. With regard to Dicer-2 and ABL1, lab M, H, X and R belong to the best 
  
 
performers, lab E, I and U show medium performance, whereas labs FBac-to-Bac, L, K, C, D and 
V show lowest performance (Fig. 3AB, Fig. 4B). FMRP, also in agreement with expression 
levels from total lysates was purified at medium to high performance from most labs (Lab M, 
H, X, I, FBac-to-Bac, E, L, R, U, FflashBAC and K) but at low levels in Lab C, D and V. Most 
striking for this particular protein is the fact that pronounced differences in expression levels 
are not necessarily reflected in protein yields. As an example, lab X and lab U showed 43% 
and 9% expression level in total lysates respectively, but comparable yields from protein 
purification (Fig. 3C and Fig. 4B). This is probably due to limited solubility of FMRP protein 
that could not be overcome by adding 0.5% Chaps to all purification buffers (see Methods). 
For NS1-H1, in analogy to expression levels in total lysates, protein yields are highest in lab 
M, X, R, U, H, medium in Lab E and low in lab I, L, K, C, D and V (Fig. 3D and Fig. 4B). In 
order to compare protein homogeneity, dynamic light scattering was recorded for all purified 
proteins to quantify aggregate content. While purities of Dicer-2 and ABL1 preparations were 
too low for meaningful data interpretation (data not shown), no significant differences in 
protein qualities of FMRP and NS1-H1 with respect to aggregate content could be detected 
(Supplementary S4). 
3.3. Trends in performance differences  
As described under sections 3.1. and 3.2. and illustrated in Figs. 2 to 4 and Table 2, we have 
observed major differences in the competence to express the target proteins Dicer-2, ABL1, 
FMRP and NS1-H1 in insect cells in the participating laboratories. For all constructs, there 
are a few high performers (M, H, X and R), some medium performers (E, FflashBacULTRA™, K, 
U) and some very low performers (L, C, D, V). The key question remains, which of the 
parameters in the respective procedures (Table 2) account(s) for high performance. A specific 
look at the high performer labs M, H, X and R shows that there is no straightforward answer, 
while they used 3 different baculovirus vectors; 2 types of cell lines; 4 different media; 3 
  
 
different flask types; with various amounts of virus used for infecting 500 ml culture (from 
1:18 to 1:125); expression times ranging from 48 to 120 h and incubation temperatures at 21 
or 27 °C. There are, however, striking relations. First of all, in direct comparison of the 
performance of the baculoviral vectors by plotting the scored overall performance of 
expression levels and protein yields of laboratories using non-modified baculoviruses (Bac-to-
Bac
®
 and ProGreen
TM
) versus all laboratories using baculoviruses carrying gene deletions 
ΔchiA, Δv-cath/chiA or Δv-cath/chiA/p10/p74/p26 (MultiBac®, EMBacY, flashBacTM 
flashBacULTRA
TM
, DefBac) indicates a clear benefit of the v-cath and chiA gene deleted 
versions of the bacmid backbone for expression of all four target proteins (Fig. 5AB). This 
observation is in agreement with previous studies (Berger et al., 2004; Hitchman et al., 2010a) 
supporting the beneficial effect of these baculoviral gene deletions for heterologous protein 
expression. This effect may be due to accumulation of chitinase (chiA) in the endoplasmic 
reticulum (Thomas et al., 1998) which may interfere with recombinant proteins targeted to the 
secretory pathway of the cells (Possee et al., 1999). Its deletion favours the production of 
secreted proteins (Possee et al., 2008). Since it also acts as activator of the baculoviral 
protease v-cath, which itself has a negative effect on recombinant protein stability, double 
deletions of v-cath/chiA have been introduced into many commonly used baculoviruses  
(Berger et al., 2004; Kaba et al., 2004). Additional gene deletions p10, p26, p74 have been 
shown to further enhance protein expression (Hitchman et al., 2010b). The labs (4 out of 14) 
using non-modified baculovirus performed with only limited success in expression of the 
selected set of proteins (Fig. 5). 
Furthermore, a clear difference in performance was revealed by directly comparing the 
difference in expression levels (Fig. 3A-D) and protein yields (Fig. 4AB) between 
laboratories using transposition-based gene integration (Bac-to-Bac
®
, MultiBac® and 
EMBacY) and laboratories using recombination-based transfection (flashBAC™, 
flashBACULTRA™, ProGreenTM and DefBac). Most high and medium performing labs can 
  
 
be found in the transposition-based integration group (M, H, X, E) whereas most low 
performing labs (C, D, K, V) are among the users of recombination-based transfection. 
Plotting the scored overall performance of all groups using Bac-to-® MultiBac® and 
EMBacY versus the users of flashBAC™, flashBACULTRA™, ProGreenTM and DefBac 
shows a two-fold higher performance of the transposition-based gene integration group (Fig. 
6AB). This comparison was intentionally planned to be unbiased, meaning that all other 
parameters used in this BEVS study such as cell line, medium, expression conditions (Table 
2) have not been standardized. Therefore, the observation that users of transposition-based 
integration perform better is a significant enough trend to justify several follow-up 
experiments. 
3.5. Follow-up study to identify key parameters for high performance  
To further strengthen the impact of the type of BEVS (transposition based gene integration 
versus recombinant-based transfection) on protein expression in insect cells, a follow-up 
study using standardized parameters was initiated. In the initial 13 lab-study, most medium 
and high performers (lab E, H, M and X) used the EMBacY baculovirus, which carries the v-
cath/chiA deletion plus an additional integrated copy of YFP as a fluorescent marker. The 
purpose of the follow-up experiments was to compare protein expression by low and medium 
performers between EMBacY and their respective recombinant-based transfection BEVS 
keeping all other parameters such as cell line, medium, incubation temperature, etc constant. 
Labs D (flashBAC
TM
), F (flashBACULTRA
TM
), and V (ProGreen
TM
) volunteered to 
participate. In addition, one low performing lab among the transposition-based integration 
group joined this study: lab L had used the non-modified Bac-to-Bac® BEVS, which was 
now compared with the Δ v-cath/chiA EMBacY baculovirus. Three genes of the prior study 
were selected for the follow-up study. All participants were provided with recombinant 
EMBacY bacmid DNA of constructs Dicer-2, ABL1 and FMRP and asked to proceed 
  
 
according to the initial study, except using production volumes of only 20 mL. Protein 
expression levels in total lysates were analyzed as described before. Representative results 
from lab D and F are illustrated in Fig. 6A and B. Triplicate expression samples from lab D 
using flashBAC
TM
 or EMBacY baculoviruses freshly prepared for that study under identical 
expression conditions were analysed by Easy SDS-PAGE and Cy5 quantification, as shown in 
Fig. 6A. The use of EMBacY instead of flashBAC
TM
 increased expression levels of Dicer-2 
from undetectable to 17% of total protein, for ABL1 from undetectable to 19% of total protein 
and for FMRP from 4% to 29% of total protein. A time-course of expression of Dicer-2, 
ABL1 and FMRP performed by lab F using either flashBACULTRA
TM
 or EMBacY 
baculovirus is shown in Fig. 6B. Total lysates of cells were analysed and quantified by SDS-
PAGE and the Bio-Rad Chemi-Doc XRS+ imaging system. In agreement with the initial 
study, lab F having high expression levels of 38% FMRP with flashBACULTRA
TM
,
 
could 
achieve only a slight increase to 41% using the EMBacY. However, EMBacY had a major 
impact on the difficult-to-express Dicer-2 and ABL1 protein expression levels which could be 
increased from 17% to 47% and from 5% to 15%, respectively. This effect is irrespective of 
prior optimization of the individual expression conditions for each BEVS system. Rescue of 
performance with EMBacY was accordingly successful for labs V and L, as illustrated in Fig. 
6C. Expression levels in total lysates of cells derived from both labs increased using the 
EMBacY baculovirus from undetectable to 46% for Dicer-2 (lab L), from undetectable to 
32% for ABL1 (lab L) and from undetectable to 44% for FMRP (lab V). For lab L, this rescue 
most likely relies on the use of a Δv-cath/chiA viral backbone.  
Apart from the increase in expression depending on the type of BEVS, differences in 
expression levels of Dicer-2, ABL1 and FMRP between lab D, F, L and V in the range of 
10% to 50% using the EMBacY baculovirus reveal that other parameters also affect 
performance, although to a lesser extent than the genetic phenotype of the baculoviral 
  
 
expression vector. Further fine tuning the influence of cell line, medium, amount of virus, 
infection time, etc, on expression was beyond the scope of this study.  
In summary, the follow-up study corroborates the finding from the initial 13 lab-study, that 
the use of a modified transposition-based baculovirus is favourable for expressing our 
selected set of target proteins. The proteins chosen for the study presented here are all 
intracellularly located; expressed at levels below 1 mg/L culture; include difficult-to-express 
proteins of high molecular weight like Dicer-2 (204 kDa) and ABL1 (126 kDa), have limited 
stability (Dicer-2 and ABL1) or solubility (FMRP). However, the results of lab R 
(flashBACULTRA
TM
) and U (DefBac, Δv-cath /chiA) show that the recombination-based 
transfection baculovirus also has the potential to achieve prosperous results in expressing 
Dicer-2, ABL1, FMRP and NS1-H. The most important remaining question is: why do most 
labs within this study using recombinant-based transfection only express limited amounts of 
this particular set of target proteins, even though 6 out of 7 are using baculovirus variants 
carrying deletions of ΔchiA, Δv-cath/chiA or Δv-cath /chiA/p10/p74/p26, shown to be 
beneficial for protein expression as described above? The lack of expression of Dicer-2, 
ABL1, FMRP and NS1-H1, more or less pronounced in lab C, D, F, K, and V is obviously not 
due to basic cell culture problems, since the performance in selected labs could be restored by 
using EMBacY. Altogether, this suggests that the procedures that were followed to enable 
recombinant-based transfection were apparently sub-optimal rather than inherent differences 
in the baculoviruses. EMBacY uses Tn7 transposition of the target gene from the 
corresponding transfer vector into the baculovirus genome within E. coli cells already 
carrying the virus genome. Recombinant baculovirus is visualized by blue-white screening 
and the bacmid DNA can be further analyzed for correct gene integration by colony-PCR or 
DNA sequencing. This additional colony-picking step followed by downstream analysis to 
ensure transposition of the entire expression cassette makes this procedure more time-
consuming, which is considered to be the major disadvantage compared to recombinant-based 
  
 
transfection, but it excludes the risk of propagating virus in which insertion of the target gene 
is somehow compromised. Furthermore, YFP integrated into EMBacY allows for monitoring 
of virus production with high sensitivity using either fluorescence microscopy or 
spectrophotometry. Since YFP is under control of the very late polyhedrin polH promotor, it 
serves as an internal marker for the infection process and for onset of protein expression, as 
the gene for the heterologous protein is usually under control of the same polH promotor. The 
recombination-based transfection baculoviral expression system instead generates 
recombinant baculovirus directly in insect cells by co-transfecting transfer vector and bacmid 
DNA. This viral DNA is per se replication-incompetent, only allowing propagation of 
recombinant virus. In contrast to the time-consuming colony picking step in the transposon-
based integration, this process is faster. However, since gene integration cannot be directly 
monitored, the quality of the recombined baculovirus for expressing the target gene may be 
less verifiable.  
As a final conclusion, the study presented here may help new users of baculovirus-mediated 
protein expression in insect cells with the many choices to be made. The BEVS strategy, 
transposition-based integration or recombination-based transfection may have a major impact 
on the result. For the proteins expressed in this study, transposition-based integration was 
favourable and resulted in substantially improving the expression levels in the benchmarking 
labs. Basically, it is highly recommended to identify the most appropriate BEVS for a given 
target protein or protein family and then further optimize and fine-tune expression with cell 
lines, media, expression conditions etc. Moreover, the protocol of choice will have to fulfill 
several additional criteria as compatibility with high throughput techniques, scalability and 
downstream processes. Eventually, there might be no one-fits-all approach and the individual 
setup will be a compromise between optimal output and practical restrictions.   
 
  
 
  
  
 
Figure Legends 
Fig. 1. Design of the study 
Fig. 2. Analysis of protein expression levels of all four proteins shown for three representative 
participants L, M and R. Blue arrowheads indicate full-length target proteins, red arrowheads 
highlight a Dicer-2 degradation product. (A) Total lysates of non-infected control cells and 
cells infected with the respective baculoviruses were loaded on 13.5% Amersham Easy SDS-
PAGE gels, visualized by Cy5 staining and quantified by the Amersham WB software. 
Expression levels are indicated as [%] of total cellular protein. Samples labelled with “nd” 
were below detection level. (B) Total lysates of non-infected control cells and cells infected 
with the respective baculoviruses were separated via capillary electrophoresis and detected 
with primary anti-penta-His antibody (Qiagen) and secondary HRP-labeled anti-mouse 
antibody using the Peggy
TM
 Simple Western system (Protein Simple).  
Fig. 3. Comparison of protein expression levels of Dicer-2 (A), ABL1 (B), FMRP (C) and 
NS1-H1 (D) from all participants grouped in two parts: on the left users of the transposition-
based integration systems (lab E, F, H, I, L, M, X), on the right users of recombination-based 
transfection systems (lab C, D, F, K, R, U, V). MB  MultiBac®, fB  flashBAC™ , Db 
DefBac, PG ProGreen™. Datasets from Easy SDS-PAGE and Simple Western are displayed 
for all constructs except for Dicer-2 and ABL1  from lab X which were analyzed only by 
Easy SDS-PAGE (see * in graphs).  In order to compare the different datasets side-by-side, 
the highest value within each dataset was set to 100% performance and all values within the 
respective dataset related to it.  
Fig. 4 Results of protein enrichment by one-step IMAC chromatography analyzed on 13.5 % 
Amersham Easy SDS-PAGE gels. MB  MultiBac®, fB  flashBAC™ (A) Imidazole eluates of 
Dicer-2, ABL1, FMRP and NS1-NH1 proteins shown for three representative participants M, 
R and U. Protein purity is indicated as [%] based on Cy5 staining and quantification by 
  
 
Amersham WB software. Respective bands are highlighted with blue arrowheads. (B) 
Comparison of protein yields of Dicer-2, ABL1, FMRP and NS1-NH1 from all participants. 
Protein yields have been derived from Bradford protein quantification corrected by protein 
purity based on Cy5 staining as shown in Fig. 4A. In order to compare protein yields and 
expression levels side-by-side, the highest protein yield value was set to 100% and all other 
values were normalized to it. Results are grouped in two parts: on the left users of the 
transposition-based integration systems (lab E, F, H, I, L, M, X), on the right users of 
recombination-based transfection systems (lab C, D, F, K, R, U, V). Labs within each group 
were ordered according to performance.  
Fig. 5: Scored performance of users of the non-modified baculoviruses (Lab FBac-to-Bac, I, L 
and V) versus users of the ΔchiA, Δv-cath/chiA or Δv-cath/chiA/p10/p74/p26 deleted 
baculoviruses (Lab C, D, FflashBAC, K, M, H, X, E, R, U) for both groups: transposition-based 
integration (lab E, F, H, I, L, M, X ) and recombination-based transfection (lab C, D, F, K, R, 
U, V). *Scores represent the sum of performances [%] divided by number of labs included in 
the respective group with regard to protein expression levels (derived from data displayed in 
Fig. 3) and protein yields (derived from data displayed in Fig. 4). Both groups are represented 
with 7 labs, thus equally weighted.  
Fig. 6: Comparison of protein expression levels of Dicer-2, ABL1 and FMRP using either the 
BEVS system from the 1
st
 study or EmBacY. (A) Lab D sample triplicates of total lysates 
expressed with flashBAC™ (virus freshly prepared for the 2nd study) or with EmBacY 
baculovirus analyzed by Easy SDS-PAGE. Expression levels are indicated as [%] of total 
cellular protein. Expression was performed in Hi5 cells at 27 °C for 72 h at virus dilutions of 
1:350 – 1:150 optimized for each individual construct in 125 mL flasks.  Blue arrowheads 
highlight the overexpressed proteins. (B) Lab F time-course of expression using either 
flashBACULTRA
TM
 or EMBacY in Hi5 cells in ESF 921 medium at 21 °C, collected after 
  
 
72, 96, 120, 144 hours post-infection (P.I. hrs) and analyzed by SDS-PAGE. Quantification 
was performed with the Bio-Rad Chemi-Doc XRS+ imaging system. (C) Expression levels as 
[%] of total cellular protein derived from quantitative Easy SDS-PAGE for labs D, L and V or 
Bio-Rad Chemi-Doc XRS+ imaging system for lab F.  Expression conditions used were 
identical to the 1
st
 study (Table 2) except use of virus instead of BIICs in lab L.  
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4 intracellular target proteins 
identical for both BEV systems 
in pFastBac for transposon-based integration  
• Bac-to-BacTM 
• MultiBac  
• EMBacY 
 
in pBac1 for integration by recombination-based transfection 
• flashBacTM 
• flashBacUltraTM 
• ProGreenTM 
• DefBac 
 
  
Use of in-house routine protocols 
• Sub-cloning (if appropriate) 
• Transfection and virus amplification  
• Small scale expression 
• 500 ml scale production of each construct 
Centralized sample analyis 
• Simple Western (VBCF) 
• SDS PAGE (MPIB) 
• Protein purification (MPIB) 
 cell densities and viabilities 
 3 x 500 µl cell pellets  
 2 x 10 ml  cell pellets 
 Control cells 
7 laboratories 
E, F, I, L, M, H, X 
7 laboratories  
C, D, F, K, R, U, V 
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Table 1  
Protein candidates in benchmarking exercise 
Number Protein  
UniProt 
entry MW [kDa] Tag 
Typical yield* 
[mg/L] 
 1 
2 
3 
 
mDicer-2  
 
A1ZAW0 203.9  N-His6 -TEV-Flag < 1    
2 hcABL1wt 
 
 
 
 
P00519 126.4  N-His6 -TEV  < 1 
3 
4 
hFMRP 
 
P35922-2 69.9 N-His6 -TEV  < 1 
4 vNS1-H1 
 
P03133 78.4  N-His6 - TEV < 1  
*Typical yield after protein purification. 
  
  
 
Table 2 Expression parameters and conditions 
La
b 
BEVS 
Gene deletions 
of BEVS 
Cell 
line 
Medium 
Amou
nt 
virus 
used 
for 
infecti
on per 
culture 
volum
e 
Cell 
densit
y at 
infecti
on 
[x 10
6
 
cells/
ml] 
Time 
of 
harve
st 
[hpi] 
Incubati
on temp 
[°C] 
Productio
n Flask 
C 
flashBACUltr
aTM 
Δv-
cath/chiA/p10/
p74 
Sf21 
EX-CELL® 
420 
1:10 0.6 48 28 
3 L 
Corning 
D flashBACTM ΔchiA 
Hi5/S
9 
SFX-
Insect 
1:100 - 
1:35 
1 72-96 27 
3 L 
Corning  
E EMBacY Δv-cath/chiA Sf9 
Sf-900™ 
II  
1:2000 0.9 72 27 1.8 L 
Fernbach 
F Bac-to-Bac® none Hi5 
Sf-900™ 
II  
1:66 1.5 96-
120 
21 
 
2.8 L 
Fernbach 
F 
flashBACUltr
aTM  
Δv-
cath/chiA/p10/
p74 
Hi5 
Sf-900™ 
II  
1:66 1.5 72-
144 
21 
2.8 L 
Fernbach 
H MultiBac® Δv-cath/chiA Sf21 
Sf-900™ 
III  
1 :100-
1 :18 
0.35 – 
1.4 
72-
120 
27 3 L glass 
EM 
I Bac-to-Bac® 
 
none 
 
Sf21 
Insect-
XPRESS™ 
1:50 1 72 
28 
 
2 L glass 
EM 
K 
flashBACUltr
a
TM
 
Δv-
cath/chiA/p10/
p74 
Hi5/S
f9 
EX-CELL® 
405/ 420 
1:130-
1:33 
1.3 -3 48-96 27 
2 L glass 
EM 
L Bac-to-Bac® none 
Hi5, 
Sf9 
EX-CELL® 
420 
1:1000 
- 1:250 
1 72 26 
 
1.8 L 
Thomson, 
2 L Vitlabb 
M EMBacY Δv-cath/chiA Hi5 
Sf-900™ 
II  
1:125 1 68-72 26 3 L 
Corning 
R 
flashBACUltr
a
TM
 
Δv-
cath/chiA/p10/
p74 
Sf21 
propriet
ary 
 1:33 1,5 - 2 48 27 
 2 L glass 
EM 
U DefBac
*
 Δv-cath/chiA Sf9 
ESF 
921™ 
1:100 1 72-96 27 
1.8 L 
Fernbach  
V ProGreenTM none Hi5 
ESF 
921™ 
1:30 1 48-72 27 
2 L 
Fischerbra
nd  
X EMBacY Δv-cath/chiA Hi5 
ESF 
921™ 
1:500 1 72 27 2 L glass 
EM + 
baffles 
* 
uses recombination based transfection; manuscript in preparation by Lab U. 
 
